Stereotaxis, Inc. Common Stock (STXS) is a publicly traded Healthcare sector company. As of July 21, 2026, STXS trades at $1.47 with a market cap of $149.44M and a P/E ratio of -6.10. STXS moved -2.33% today. Year to date, STXS is -34.50%; over the trailing twelve months it is -35.34%. Its 52-week range spans $1.46 to $3.59. Analyst consensus is strong buy with an average price target of $4.17. Rallies surfaces STXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover STXS: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $4.17.
| Metric | Value |
|---|---|
| Price | $1.47 |
| Market Cap | $149.44M |
| P/E Ratio | -6.10 |
| EPS | $-0.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.59 |
| 52-Week Low | $1.46 |
| Volume | 1.47M |
| Avg Volume | 0 |
| Revenue (TTM) | $-681.00K |
| Net Income | $-21.68M |
| Gross Margin | -2467.11% |
3 analysts cover STXS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.17.